These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


196 related items for PubMed ID: 26633178

  • 1. Chemotherapy with Gemcitabine and Cisplatin for Advanced Ductal Adenocarcinoma of the Prostate: Clinical Courses of Two Patients.
    Kamiyama Y, Mitsuzuka K, Watanabe M, Kawamorita N, Yamada S, Kaiho Y, Ito A, Nakagawa H, Arai Y.
    Tohoku J Exp Med; 2015 Dec; 237(4):317-21. PubMed ID: 26633178
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Docetaxel and cisplatin in patients with metastatic androgen independent prostate cancer and circulating neuroendocrine markers.
    Culine S, El Demery M, Lamy PJ, Iborra F, Avancès C, Pinguet F.
    J Urol; 2007 Sep; 178(3 Pt 1):844-8; discussion 848. PubMed ID: 17631339
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Combination chemotherapy with gemcitabine with isolated lung perfusion for the treatment of pulmonary metastases.
    Van Putte BP, Hendriks JM, Romijn S, Pauwels B, Vermorken JB, Van Schil PE.
    J Thorac Cardiovasc Surg; 2005 Jul; 130(1):125-30. PubMed ID: 15999051
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Phase II study of fixed dose rate gemcitabine with cisplatin for metastatic adenocarcinoma of the pancreas.
    Ko AH, Dito E, Schillinger B, Venook AP, Bergsland EK, Tempero MA.
    J Clin Oncol; 2006 Jan 20; 24(3):379-85. PubMed ID: 16344320
    [Abstract] [Full Text] [Related]

  • 12. Gemcitabine and Cisplatin is a highly effective combination chemotherapy in patients with advanced cancer of the gallbladder.
    Malik IA, Aziz Z, Zaidi SH, Sethuraman G.
    Am J Clin Oncol; 2003 Apr 20; 26(2):174-7. PubMed ID: 12714891
    [Abstract] [Full Text] [Related]

  • 13. Phase I dose-escalation trial of gemcitabine and cisplatin for advanced non-small-cell lung cancer: usefulness of mathematic modeling to determine maximum-tolerable dose.
    Shepherd FA, Burkes R, Cormier Y, Crump M, Feld R, Strack T, Schulz M.
    J Clin Oncol; 1996 May 20; 14(5):1656-62. PubMed ID: 8622085
    [Abstract] [Full Text] [Related]

  • 14. Oxaliplatin plus gemcitabine as a salvage schedule for hormone-refractory prostate adenocarcinoma.
    Santisteban M, Pérez-Gracia JL, Ceballos J, Vivas I, García-Foncillas J.
    Clin Transl Oncol; 2008 Jun 20; 10(6):372-4. PubMed ID: 18558585
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Refractory non-small-cell lung cancer responding to combination chemotherapy with gemcitabine and cisplatin].
    Miyazawa M, Hyougotani A, Koyama H, Haba T, Katoh K, Muramatsu A, Ozawa K.
    Gan To Kagaku Ryoho; 2002 Jul 20; 29(7):1227-30. PubMed ID: 12146004
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Active chemotherapy with gemcitabine, carboplatin and docetaxel for three patients with MVAC-resistant liver metastasis of urothelial carcinoma].
    Inoue T, Ohyama C, Horikawa Y, Togashi H, Matsuura S, Tsuchiya N, Satoh S, Sato K, Habuchi T, Saito S, Hoshi S, Arai Y, Kato T.
    Hinyokika Kiyo; 2004 Apr 20; 50(4):273-7. PubMed ID: 15188623
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.